A detailed history of Sandy Spring Bank transactions in Viatris Inc stock. As of the latest transaction made, Sandy Spring Bank holds 700 shares of VTRS stock, worth $8,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Previous 579 20.9%
Holding current value
$8,764
Previous $6,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$10.32 - $12.13 $1,248 - $1,467
121 Added 20.9%
700 $8,000
Q2 2024

Aug 06, 2024

BUY
$10.05 - $12.02 $331 - $396
33 Added 6.04%
579 $6,000
Q1 2024

May 08, 2024

SELL
$11.27 - $13.53 $3,414 - $4,099
-303 Reduced 35.69%
546 $6,000
Q4 2023

Jan 26, 2024

BUY
$8.77 - $10.85 $1,736 - $2,148
198 Added 30.41%
849 $9,000
Q3 2023

Oct 30, 2023

SELL
$9.59 - $11.35 $11,958 - $14,153
-1,247 Reduced 65.7%
651 $6,000
Q2 2023

Aug 04, 2023

BUY
$9.02 - $10.29 $117 - $133
13 Added 0.69%
1,898 $18,000
Q1 2023

May 05, 2023

BUY
$9.2 - $12.26 $11,362 - $15,141
1,235 Added 190.0%
1,885 $18,000
Q3 2022

Nov 02, 2022

SELL
$8.48 - $11.13 $907 - $1,190
-107 Reduced 14.13%
650 $5,000
Q2 2022

Jul 21, 2022

BUY
$9.95 - $12.27 $746 - $920
75 Added 11.0%
757 $8,000
Q1 2022

May 03, 2022

BUY
$9.81 - $15.4 $500 - $785
51 Added 8.08%
682 $8,000
Q4 2021

Feb 11, 2022

BUY
$12.09 - $14.68 $278 - $337
23 Added 3.78%
631 $9,000
Q3 2021

Nov 05, 2021

SELL
$13.25 - $15.13 $13,475 - $15,387
-1,017 Reduced 62.58%
608 $8,000
Q2 2021

Aug 09, 2021

BUY
$12.97 - $16.15 $1,245 - $1,550
96 Added 6.28%
1,625 $23,000
Q1 2021

May 03, 2021

SELL
$13.59 - $18.54 $6,006 - $8,194
-442 Reduced 22.43%
1,529 $22,000
Q4 2020

Feb 03, 2021

BUY
$14.3 - $18.74 $28,185 - $36,936
1,971 New
1,971 $37,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Sandy Spring Bank Portfolio

Follow Sandy Spring Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandy Spring Bank, based on Form 13F filings with the SEC.

News

Stay updated on Sandy Spring Bank with notifications on news.